Ashland
Ashland Inc is an American specialty chemicals manufacturer supplying additives, ingredients, and functional materials across global consumer and industrial markets. The company operates through business segments including Life Sciences, Personal Care & Household, Specialty Additives, and Intermediates, producing cellulose ethers, synthetic polymers, bio-based additives, and specialty solvents. Principal revenues are generated from wholesale product sales directly to pharmaceutical formulation firms, personal care brand owners, architectural paint makers, and industrial processors. Core end markets encompass pharmaceutical tablet manufacturing, cosmetics, home care products, architectural coatings, and construction materials globally. Ashland holds a market-leading position in cellulosics and specialty ingredients for pharmaceutical and personal care applications. The corporation is headquartered in Wilmington, Delaware, and its common stock trades on the New York Stock Exchange.
7 of the funds FundTelligence covers report a position in Ashland.
- Sector
- Materials
- Country
- United States
- Funds holding it
- 7
Funds holding Ashland
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.3 % (full portfolio disclosed, September 2026)
- Mercer Global High Yield Bond Fund — Mercer · 0.24 % (full portfolio disclosed, December 2025)
- DNB Global Enhanced Small Cap — DNB · 0.03 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.03 % (partially disclosed portfolio, June 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)
- Nordea Internationale aktier — Nordea Funds · 0.02 % (full portfolio disclosed, September 2026)
- MGI Global Bond Fund — Mercer · 0.01 % (full portfolio disclosed, December 2025)